← All trials
NCT01066026
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2009
- Primary completion
- Jan 31, 2010
- Completion date
- Mar 31, 2010
- First posted
- Feb 10, 2010
- Last posted
- Oct 1, 2020
- Enrollment
- 25
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hexsel Dermatology ClinicLead sponsor
- Pontifical Catholic University of Rio Grande do SulLead sponsor
- Pontifical Catholic University of Rio Grande do SulReponsible party - principal investigator
- Pontifical Catholic University of Rio Grande do SulSponsor investigator
- Hexsel Dermatology ClinicSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.